From Spark to Inferno: How Chinese Biopharma Innovation is Forging the Future of Global Oncology Deal Making | Ipsos
From Spark to Inferno: How Chinese Biopharma Innovation is Forging the Future of Global Oncology Deal Making | Ipsos

From Spark to Inferno

How Chinese Biopharma Innovation is Forging the Future of Global Oncology Deal Making.

China is emerging as an engine of therapeutic innovation, with its science now setting the pace in some of the most competitive areas of drug development, particularly in oncology.

Landmark deals, rapid early-stage data and a unique clinical ecosystem are reshaping how global companies source innovation, structure partnerships, and plan their oncology portfolios.

Ipsos’ latest white paper unpacks what this shift means for business development, strategy and investment teams.

This Point of View explores how Chinese biopharma innovation is reshaping the rules of engagement in global oncology, and where the next wave of opportunity is likely to emerge. Drawing on pipeline comparisons, deal case studies and ecosystem analysis, it helps decision makers distinguish signal from noise.

In our latest Ipsos white paper, our experts reveal:

  • Examining the landmark deals that acted as catalysts
  • Demonstrating how early data from China can ignite partnerships and global interest
  • Exploring the unique ecosystem that enables this innovation
  • Identifying the strategic challenges and how organisations can navigate this complex environment
     

Download

The author(s)

More insights about Health

Related news

  • The Human Advantage Conference 2026: Highlights
    Artificial Intelligence (AI) Events replay

    The Human Advantage Conference 2026: Highlights

    Ipsos is proud to support The Human Advantage 2026, a flagship event bringing together some of the world's leading experts and key industry figures to explore how behavioural science, AI, and human intelligence can address the critical challenges facing businesses and society. Here's a look back at two days of live coverage.
  • [WEBINAR] KEYS: Dialling Up the S In Sustainability
    KEYS Events replay

    [REPLAY] KEYS: Dialling Up the S In Sustainability

    In the next episode of our KEYS webinar, we’ll be asking whether now is the time when organisations should be ‘dialling up the S’ in their sustainability initiatives.
  • [Webinar] Real-World Evidence: Empowering the Patient
    Healthcare Webinar

    [Replay] Real-World Evidence: Empowering the Patient

    Patient voices are now central to regulatory, HTA and commercial decisions. But how do we move beyond tick-box engagement to evidence that truly reflects lived experience? Join our expert panel for a 360° perspective on making patient-centricity work in practice.